Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 80,663,007
- Share change
- +154,436
- Total reported value
- $45,172,000
- Price per share
- $0.56
- Number of holders
- 17
- Value change
- +$87,373
- Number of buys
- 8
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
72,873,494
|
$80,890,000 | — | 30 Sep 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
4.5%
|
6,254,458
|
$6,942,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.49%
|
680,800
|
$756,000 | — | 30 Sep 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
495,900
|
$550,000 | — | 30 Sep 2021 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.03%
|
48,236
|
$54,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
31,662
|
$35,000 | — | 30 Sep 2021 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
24,599
|
$27,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
22,800
|
$25,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
22,473
|
$25,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
21,204
|
$23,000 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
20,069
|
$22,000 | — | 30 Sep 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
12,876
|
$14,000 | — | 30 Sep 2021 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q4 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.